key: cord-0254938-56kdx345
authors: Patterson, LaNisha L.; Velayutham, Thangam Sudha; Byerly, Caitlan D.; Bui, Duc Cuong; Patel, Jignesh; Veljkovic, Veljko; Paessler, Slobodan; McBride, Jere W.
title: Ehrlichia SLiM ligand mimetic activates Notch signaling in human monocytes
date: 2022-01-15
journal: bioRxiv
DOI: 10.1101/2022.01.13.476283
sha: 292dd9c602e36a7bf89943649cd5c8bbc0be421b
doc_id: 254938
cord_uid: 56kdx345

Ehrlichia chaffeensis evades innate host defenses by reprogramming the mononuclear phagocyte through mechanisms that involve exploitation of multiple evolutionarily conserved cellular signaling pathways including Notch. This immune evasion strategy is directed in part by tandem repeat protein (TRP) effectors. Specifically, the TRP120 effector activates and regulates Notch signaling through interactions with the Notch receptor and the negative regulator, F-Box and WD repeat domain-containing 7 (FBW7). However, the specific molecular interactions and motifs required for E. chaffeensis TRP120-Notch receptor interaction and activation have not been defined. To investigate the molecular basis of TRP120 Notch activation, we compared TRP120 with endogenous canonical/non-canonical Notch ligands and identified a short region of sequence homology within the tandem repeat (TR) domain. TRP120 was predicted to share biological function with Notch ligands, and a function-associated sequence in the TR domain was identified. To investigate TRP120-Notch receptor interactions, colocalization between TRP120 and endogenous Notch-1 was observed. Moreover, direct interactions between full length TRP120, the TRP120 TR domain containing the putative Notch ligand sequence, and the Notch receptor LBR were demonstrated. To molecularly define the TRP120 Notch activation motif, peptide mapping was used to identify an 11-amino acid short linear motif (SLiM) located within the TRP120 TR that activated Notch signaling and downstream gene expression. Peptide mutants of the Notch SLiM or anti-Notch SLiM antibody reduced or eliminated Notch activation and NICD nuclear translocation. This investigation reveals a novel molecularly defined pathogen encoded Notch SLiM mimetic that activates Notch signaling consistent with endogenous ligands. Importance E. chaffeensis infects and replicates in mononuclear phagocytes, but how it evades innate immune defenses of this indispensable primary innate immune cell is not well understood. This investigation reveals the molecular details of a ligand mimicry cellular reprogramming strategy that involves a short linear motif (SLiM) which enables E. chaffeensis to exploit host cell signaling to establish and maintain infection. E. chaffeensis TRP120 is a moonlighting effector that has been associated with cellular activation and other functions including ubiquitin ligase activity. Herein, we identify and demonstrate that a SLiM present within each tandem repeat of TRP120 activates Notch signaling. Notch is an evolutionarily conserved signaling pathway responsible for many cell functions including cell fate, development, and innate immunity. The proposed study is significant because it reveals the first molecularly defined pathogen encoded SLiM that appears to have evolved de novo to mimic endogenous Notch ligands. Understanding Notch activation during E. chaffeensis infection provides a model in which to study pathogen exploitation of signaling pathways and will be useful in developing molecularly-targeted countermeasures for inhibiting infection by a multitude of disease-causing pathogens that exploit cell signaling through molecular mimicry. Author Summary E. chaffeensis is a small, obligately intracellular, Gram-negative bacterium that has evolved cellular reprogramming strategies to subvert innate defenses of the mononuclear phagocyte. Ehrlichial TRP effectors interface with the host cell and are involved in pathogen-host interplay that facilitates exploitation and manipulation of cellular signaling pathways; however, the molecular interactions and functional outcomes are not well understood. This study provides molecular insight into a eukaryotic mimicry strategy whereby secreted effectors of obligately intracellular pathogens activate the evolutionarily conserved Notch signaling pathway through a short linear motif ligand mimetic to promote intracellular infection and survival.

E. chaffeensis infects and replicates in mononuclear phagocytes, but how it evades innate 28 immune defenses of this indispensable primary innate immune cell is not well understood. This 29 investigation reveals the molecular details of a ligand mimicry cellular reprogramming strategy 30 that involves a short linear motif (SLiM) which enables E. chaffeensis to exploit host cell 31 signaling to establish and maintain infection. E. chaffeensis TRP120 is a moonlighting effector 32 that has been associated with cellular activation and other functions including ubiquitin ligase 33 activity. Herein, we identify and demonstrate that a SLiM present within each tandem repeat of 34 TRP120 activates Notch signaling. Notch is an evolutionarily conserved signaling pathway 35 responsible for many cell functions including cell fate, development, and innate immunity. The 36

proposed study is significant because it reveals the first molecularly defined pathogen encoded 37

SLiM that appears to have evolved de novo to mimic endogenous Notch ligands. Understanding 38

Notch activation during E. chaffeensis infection provides a model in which to study pathogen 39 exploitation of signaling pathways and will be useful in developing molecularly-targeted 40 countermeasures for inhibiting infection by a multitude of disease-causing pathogens that 41 exploit cell signaling through molecular mimicry. 42 43

Ehrlichia chaffeensis is a small, obligately intracellular, Gram-negative tick transmitted 54 bacterium (1) that exhibits tropism for mononuclear phagocytes. E. chaffeensis establishes 55 infection through a multitude of cellular reprogramming strategies that involve effector-host 56 interactions resulting the in activation and manipulation of cell signaling pathways to suppress 57 and evade innate immune mechanisms (2-8). The mechanisms whereby E. chaffeensis evades 58 host defenses of the macrophage involves exploitation of Wnt and Notch signaling by the 59 tandem repeat protein (TRP) effector, TRP120 (2-6). 60 E. chaffeensis TRP120 effector has well-documented moonlighting functions that include 61 roles as a nucleomodulin (9, 10), a HECT E3 ubiquitin ligase (2, 7, 11), and as a ligand mimic 62 (3, 5, 6, 12) . Previously, we found that TRP120 is involved in a diverse array of host cell 63 interactions including components of signaling and transcriptional regulation associated with 64 Wnt and Notch signaling pathways (8). We have recently shown that TRP120 ubiquitinates the 65 Notch negative regulator FBW7 resulting in increased NICD levels, as well as other FBW7 66 regulated oncoproteins during infection (2). In addition, we have also demonstrated that E. 67 chaffeensis Notch activation results in downregulation of toll-like receptor 2 and 4 expression, 68

likely as an immune evasion mechanism (6). Although we have demonstrated TRP120 activates 69

Notch signaling, the molecular details involved in activation have yet to be defined. 70

The Notch signaling pathway is evolutionarily conserved and is known to play a critical 71 role in cell proliferation, differentiation, and apoptosis in all metazoan organisms (13-16). Notch 72 activation plays significant roles in various other cellular outcomes, including MHC Class II 73 expansion (17), B-and T-cell development (18), and innate immune mechanisms such as 74 autophagy (19) and apoptosis (20, 21) . Canonical Notch activation is driven by direct cell-75 membrane bound receptor-ligand interactions with four Notch receptors (Notch1-4) and 76

canonical Notch ligands, Delta-like (DLL 1,3,4) and Jagged (Jagged/Serrate-1 and 2). Notch 77 receptor-ligand interactions occur at the Notch extracellular domain (NECD), specifically at 78 epidermal growth factor-like repeats (EGFs) 11-13, the known ligand binding domain (LBD) . diverse array of host proteins through several well-known protein-protein interaction 100 mechanisms including post-translational modifications (PTMs), and various protein interaction 101 modules located in intrinsically disordered domains (IDDs) (7, 9, 26, 28) . 102 tagged full length TRP120 (TRP120-FL-GFP) in HeLa cells and probed for endogenous Notch-1 152 to determine colocalization. Pearson's correlation coefficient (PC) and Mander's coefficient (MC) 153 (correlation range +1 to −1; 0 represents absence of correlation), was used to quantify the 154 degree of colocalization between TRP120-FL-GFP and Notch-1. Ectopically expressed 155 TRP120-FL-GFP was found to strongly colocalize (PC = 0.897 and MC = 0.953) with 156 endogenous Notch-1 ( Fig. 2A) . Colocalization of TRP120 and Notch-1 demonstrates that these 157 two proteins are in the same spatial location; however, it does not demonstrate direct protein-158 protein interaction. To confirm a direct interaction, we utilized pull-down assays of TRP120-FL 159

and Notch-1 LBR. A His-tagged rTRP120-FL (rTRP120-FL-His) construct was incubated with a 160

Fc-tagged recombinant Notch-1 LBR, and a direct protein-protein interaction was demonstrated 161 (Figs. 2B and S2A-B) . Thioredoxin (TRX), used as a fusion tag in the pBAD expression vector 162 containing TRP120 constructs and as a recombinant control, did not interact (Fig. 2B) . Based on 163 sequence homology and ISM data, a short region of sequence homology within the tandem 164 repeat (TR) domain was identified that could be involved in the TRP120 and Notch-1 LBR. To 165 determine if the TRP120-TR was responsible for the previous TRP120 and Notch-1 LBR 166 interaction, we performed a pull-down assay with TRP120-TR and Notch-1 LBR. rTRP120-TR 167 was pulled down with anti-Notch-1 LBR antibody demonstrating a direct interaction with the TR 168 domain (Fig. 2C) . 169

To further confirm direct interaction of TRP120-FL or TRP120-TR and Notch-1 LBR, 170 surface plasmon resonance was performed. An interaction between both rTRP120-FL (Fig. 2D ) 171 and rTRP120-TR ( Fig. 2E) with Notch-1 LBR was detected in a concentration dependent 172 manner. Fitting the concentration response plots for TRP120-FL and TRP120-TR yielded a K D 173 (equilibrium dissociation constant) of 100 ± 3.5 nM and 120 ± 2.0 nM, respectively (Figs. 2D-E). 174

No interaction was detected between TRX and Notch-1 LBR (Fig. 2F) . Additionally, treatment of 175 THP-1 cells with TRP120-coated sulfate, yellow-green microspheres demonstrated 176 colocalization of have previously demonstrated Notch activation occurs in THP-1 cells after stimulation with 184 TRP120-coated beads for 15 min (6). Gene expression levels of notch1, hes1 and hes5 were 185 upregulated after incubation with TRP120-coated beads. To further delineate the TRP120 186 domain required for Notch activation THP-1 cells or primary human monocytes were treated 187 with soluble purified full length or truncated constructs of recombinant TRP120 (rTRP120-TR Collectively, these data demonstrate the requirement of TRP120-TR for Notch activation. To determine if Notch is activated by a TRP120-TR Notch mimetic IDD motif, several TRP120-195 TR synthetic peptides were generated (Fig. 4A ). THP-1 cells or primary human monocytes were 196 treated with TRP120-TR IDD peptides or scrambled negative control peptide for 2 h. A 35-aa 197 TRP120-TR IDD motif (TRP120-N1-P3) caused nuclear translocation (Figs. 4B and C). 198 Importantly, the identified IDD contained a motif identified in both sequence homology and ISM 199 data (Fig. 1C) . Inhibition of Notch signaling by DAPT, a γ-secretase inhibitor, abrogated Notch 200 activation with TRP120-N1-P3 treatment, indicating that TRP120-N1-P3 directly binds to the 201 Notch-1 receptor for Notch activation (Fig. 4B ). To confirm Notch activation by TRP120-N1-P3, 202 gene expression levels of Notch downstream targets were examined by human Notch signaling 203 pathway array analysis. In comparison to untreated THP-1 cells, a significant increase in Notch 204 downstream targets, including HES1, HES5, HEY1 and HEY2 gene expression levels occurred 205 in TRP120-N1-P3 treated cells (Figs. 5A-B, Table S1A ). Interestingly, Notch gene expression by 206 TRP120-N1-P3 treatment was increased in a concentration-dependent manner (Fig. 5B , Table  207 S1A). Importantly, rJagged-1 also demonstrated similar upregulation of Notch genes in a 208 concentration-dependent manner (Fig. S3 ). These data demonstrate that a TRP120 IDD 209 mimetic motif is responsible for TRP120 Notch activation. 210

It is well-documented that SLiMs are found in two general groups; posttranslational modification 213 (PTM) motifs or ligand motifs that mediate binding events. We have previously identified a 214 functional TRP120 HECT E3 ligase catalytic motif located in the C-terminus (2, 7) and have 215 recently identified a TRP120-TR Wnt SLiM mimetic motif (3). To determine if the TRP120-TR 216

Notch mimetic motif could be a SLiM (3-12 aa), overlapping TRP120-TR synthetic peptides that 217 span the identified 35-aa TRP120-TR IDD motif were synthesized (Fig. 6A) . Treatment with P4 218 and P5 TRP120-TR Notch mimetic SLiM peptides in THP-1 cells did not result in NICD nuclear 219 translocation (Fig. 6B) ; however, TRP120-TR Notch mimetic SLiM P6 (TRP120-N1-P6) located 220 at the C-terminus resulted in NICD nuclear translocation (Fig. 6B ). TRP120-N1-P6 was also 221 shown to cause NICD nuclear translocation in primary human monocytes (Fig. 6C) . 222

Furthermore, pre-treatment of DAPT inhibited TRP120-N1-P6 Notch activation (Fig. 6B) . 223

Upregulation of Notch downstream targets occurred with TRP120-N1-P6 treatment in a 224 concentration dependent manner (Figs. 7A-B, Table S1B), as previously shown with the 225 TRP120-N1-P3 peptide. In comparison, TRP120-N1-P5 peptide treatment, did not result in 226 significant upregulation of Notch gene expression (Fig. 7B) . 227

To confirm that TRP120-N1-P6 is required for Notch activation, a TRP120-N1-P3 mutant 228 peptide (dmut) (Fig. 6A ) without the TRP120-N1-P6 motif was tested. THP-1 cells stimulated 229 with TRP120-N1-dmut exhibited abrogated Notch activation as demonstrated by NICD 230 translocation (Fig. 6B ). To determine the minimal residues required in the TRP120-TR Notch 231 mimetic SLiM, alanine mutagenesis was used to determine the contribution of specific residues 232 to Notch activation (Fig. 8A , blue boxes). Mutated residues were selected based on sequence 233 homology and ISM data. Mutants (dmut-1 -2, -3 and -4) exhibited reduced Notch activation as 234 determined by NICD translocation, but only the TRP120-N1-dmut peptide resulted in full 235 abrogation of NICD nuclear translocation (Fig. 8A) . Collectively, these data demonstrate that the 236 TRP120-N1-P6 SLiM is a Notch mimetic. 237

whether the TRP120 Notch mimetic is solely responsible for Notch activation by E. chaffeensis, 240 THP-1 cells were pre-treated with a purified rabbit polyclonal antibody generated against the 241 TRP120-N1-P6 SLiM and subsequently infected with E. chaffeensis for 2 h. Negative pre-242 immune serum was used as a negative control. NICD nuclear translocation was determined in 243 α-TRP120-N1-P6 SLiM or negative pre-immune serum treated cells. THP-1 cells treated with α-244 TRP120-N1-P6 SLiM did not display NICD nuclear translocation, in comparison to the negative 245 pre-immune serum control (Fig. 8B ). These data suggests that TRP120-N1-P6 SLiM is the only 246

Notch mimic involved in Notch activation by E. chaffeensis. 247 248

We have previously demonstrated TRP120-host interactions to occur with a diverse 250 array of host cell proteins associated with conserved signaling pathways, including Wnt and 251 Notch (8) . Two proteins shown to interact with TRP120 were the Notch metalloprotease, a 252 disintegrin and metalloprotease domain (ADAM17), and a Notch antagonist, F-box and WD 253 repeat domain-containing 7 (FBW7). In addition, we have demonstrated that secretion of E. 254 chaffeensis TRP120 activates Notch signaling to downregulate TLR2/4 expression for 255 intracellular survival. Moreover, Keewan et al, demonstrated upregulation of Notch-1, IL-6 and 256

MCL-1 during M. avium paratuberculosis infection (37). Notch-1 signaling was shown to 257 modulate macrophage polarization and immune defense against during infection, but the 258 molecular mechanisms were not defined; however, the molecular mechanisms utilized for 259 TRP120 Notch activation have not been previously studied (6). In this study, we investigated the 260 molecular interactions involved in TRP120 Notch activation and have defined a TRP120 Notch 261

SLiM mimetic responsible for Notch activation. 262

Molecular mimicry has been well-established as an evolutionary survival strategy utilized 263 by pathogens to disrupt or co-opt host function as a protective mechanism to avoid elimination 264 by the host immune system (30, 32-36). More specifically, SLiMs are a distinct, intrinsically 265 disordered class of protein interaction motifs that have been shown to evolve de novo for 266 promiscuous binding to various partners and have been documented as a host hijacking 267 mechanism for pathogens (26, 29, 30) . Although SLiM mimicry has been established as a 268 mechanism utilized by pathogens to repurpose host cell functions for survival, a Notch ligand 269 mimic has never been defined. 270 TRP120 contains four intrinsically disordered tandem repeat (TR) domains that have 271 been previously described as important for TRP120's moonlighting capabilities (9, 12 for Notch binding and activation, but a conserved activation motif has not been defined. 292

Colocalization of TRP120 with Notch-1 was previously shown to occur during E. chaffeensis 293 infection (6); however, a direct interaction was not previously shown using yeast-two hybrid (8), 294 possibly due to limitations of this technique with protein interactions involving membrane 295 proteins (6, 41). Using pull down, SPR and protein-coated fluorescent microsphere approaches, 296

we further studied TRP120-Notch-1 interaction and found direct binding occurs through 297 TRP120-TR at a Notch-1 LBR (EGFs 1-15). TRP120-TR and Notch-1 LBR interaction occurred 298 at an affinity of 120 ± 2.0 nM, indicating a strong protein-protein interaction. Numerous structural 299 studies of interactions of Notch with endogenous ligands have shown low affinity interactions 300 between Notch Jag or DLL ECDs (42-44). One study demonstrated weak affinities between 301

Notch-1 with an engineered high affinity Jag-1 variant (K D = 5.4 µM) and DLL4 (12.8 µM) (39). 302

The higher binding affinity of TRP120-TR in comparison to canonical Notch ligands suggests 303 that the four tandemly repeated motifs folds in a structure that potentiates binding between 304 TRP120 and Notch-1. In addition, stimulating THP-1 cells and primary monocytes with TRP120-305 TR resulted in NICD nuclear translocation, indicating that TRP120-TR is the TRP120 domain 306 responsible for Notch activation. Interestingly, TRP120-Fzd5 interaction also occurred through 307 the tandem repeat domain and supports our current findings that TRP120-host protein 308

interactions occur within regions of the tandem repeat domain, likely due to its disordered nature 309

(3). 310

Secreted and membrane-bound proteins have been shown to activate Notch signaling. 311

These non-canonical Notch ligands lack the DSL domain but still have the ability to modify 312

Notch signaling. Some of the non-canonical Notch proteins contain EGF-like domains; however, 313 others share very little sequence similarity to endogenous Notch ligands (23, 45). TSP2 is a 314 secreted mammalian protein containing EGF-like domains. TSP2 was found to potentiate Notch 315 signaling by direct Notch-3/Jagged1 binding (46). Furthermore, TSP2 binds directly to purified 316

Notch-3 protein containing EGF-like domains 1-11, suggesting a direct interaction. Non-317 canonical Notch ligand TSP2 was found to share significant sequence homology within the 318 TRP120-TR sequence. Homologous regions included the identified TRP120-TR Notch SLiM 319 mimetic. Although TSP2 has been identified as a secreted, non-canonical Notch ligand, there 320 has been no activating motif identified to date. F3/contactin1, another identified secreted non-321 canonical Notch ligand, does not contain DSL or EGF-like domains; however, it activates the 322 Notch signaling pathway through the Notch-1 receptor (47). TRP120 was found to share 323 biological function with F3/contactin1 by ISM. F3/contactin1 has been demonstrated to bind to 324

Notch-1 at two different locations within the NECD and activates Notch signaling when 325 presented as purified soluble protein (47). Therefore, Notch activation by secreted, non-326

canonical Notch ligands has been demonstrated; however, more insight into the molecular 327 details of those interactions needs to be elucidated. This study provides new insight regarding 328 non-canonical Notch ligand activation of the Notch signaling pathway. Alanine mutagenesis demonstrated the entire 11-aa TRP120-TR Notch ligand SLiM 358 mimetic is required for Notch activation. Importantly, SLiMs are known to have low-affinity, 359 transient protein-protein interactions within the low-micromolar range (26). In this case, the 360 repeated TRP120-TR Notch ligand SLiM mimetic motif may cause TRP120 to fold in a tertiary 361 structure upon binding to the Notch-1 receptor that stabilizes the TRP120-Notch-1 interaction. 362

Based on this data, E. chaffeensis TRP120 could be used as a model to study SLiMs within 363 intrinsically disordered effector proteins that are utilized for host exploitation by other 364 intracellular bacterial pathogens. 365

To demonstrate that TRP120-TR Notch ligand SLiM mimetic motif is solely responsible 366 for E. chaffeensis activation of Notch, we generated an antibody against the mimetic epitope to 367 block E. chaffeensis TRP120-Notch-1 binding. Our results demonstrated antibody blockade of 368

Notch activation by E. chaffeensis, rTRP120 and the TRP120-TR Notch ligand SLiM peptide. 369

This data strongly supports the conclusion that the TRP120-TR Notch ligand SLiM mimetic is 370 responsible for E. chaffeensis Notch activation and may provide a new E. chaffeensis 371 therapeutic target. Hence, this study serves to provide insight into the molecular details of how 372

Notch signaling is modulated during E. chaffeensis infection and may serve as a model for other 373

Further outstanding questions regarding regulation of the Notch signaling pathway 375 during E. chaffeensis remain. We have recently demonstrated maintenance of Notch activation 376 is linked to TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor 377 FBW7, a Notch negative regulator (2). However, other potential Notch regulators may serve as 378 a target for TRP120-medidated ubiquitination for constitutive Notch activation during infection. 379

of Notch signaling by degrading Deltex, a positive regulator of Notch signaling (56). Su(dx) may 381 serve as another target of TRP120-mediated ubiquitination to maintain Notch activity during E. 382 chaffeensis infection. Furthermore, how secreted non-canonical Notch ligands are able to cause 383 separation between the NICD and NECD remains unknown. TRP120 causes Notch activation, 384 resulting in upregulation of Notch downstream targets; however, the mechanism of how the S2 385 exposure for ADAM cleavage is not understood. Future crystallography studies on TRP120 and 386

Notch-1 interaction may provide more insight into these structural details required for TRP120-387 N1-P6 SLiM Notch activation (57, 58) . 388

In conclusion, we have demonstrated E. chaffeensis Notch activation is initiated by a 389 TRP120 Notch SLiM mimetic. Our findings have identified a pathogen protein host mimic to 390 repurpose the evolutionarily conserved Notch signaling pathway for intracellular survival. This 391 study gives more insight into how obligate intracellular pathogens, with small genomes have 392 evolved host mimicry modules de novo to exploit conserved signaling pathways to suppress 393 innate defenses to promote infection. 394

ATCC TIB-202) were propagated in RPMI media (ATCC) containing 2 mM L-glutamine, 10 mM 398 HEPES, 1 mM sodium pyruvate, 4500 mg/L glucose,1500 mg/L sodium bicarbonate, 399 supplemented with 10% fetal bovine serum (FBS; Invitrogen) at 37°C in 5% CO 2 atmosphere. E. 400 chaffeensis (Arkansas strain) was cultivated in THP-1 cells. Host cell-free E. chaffeensis was 401 prepared by rupturing infected THP-1 cells or primary human monocytes with sterile glass 402 beads (1 mm) by vortexing. Infected THP-1 cells were harvested and pelleted by centrifugation 403 at 500 × g for 5 min. The pellet was resuspended in sterile phosphate-buffered saline (PBS) in a 404 50-ml tube containing glass beads and vortexed at moderate speed for 1 min. The cell debris 405 was pelleted at 1,500 × g for 10 min, and the supernatant was further pelleted by high-speed 406 centrifugation at 12,000 × g for 10 min, 4°C. The purified ehrlichiae were resuspended in fresh 407 RPMI media and utilized as needed. 408

Human PBMC and primary monocyte isolation. Primary human monocytes were isolated 409 from 125ml of human blood obtained from Gulf Coast Regional Blood Center (Houston, TX) . Sigma-Aldrich, Saint Louis, MO). Polyclonal rabbit anti-TRP120 antiserum was commercially 427 generated against a TRP120 epitope inclusive of aa. [290] [291] [292] [293] [294] [295] [296] [297] [298] [299] [300] [301] Piscataway, NJ) . 428

Synthetic peptides used in this study were commercially generated (Genscript, Piscataway, NJ). 429 Sequence Homology. Genome and transcriptome sequences encoding E. chaffeensis TRP120 430

and Homo sapiens Notch ligand proteins were recovered using BLAST searches with the online 431 version at the NCBI website. Sequences were submitted to NCBI Protein BLAST and ClustalW2 432 sequence databases for sequence alignment. 433

Informational Spectrum Method (ISM). ISM analyzes the primary structure of proteins by 434 assigning a physical parameter which is relevant for the protein's biological function (38, 60) . 435

Each amino acid in TRP120 and Notch ligand sequences was given a value corresponding to its 436 electron-ion interaction potential (EIIP), which determines the long-range properties of biological 437 molecules. The value of the amino acids within the protein were Fourier transformed to provide 438 a Fourier spectrum that is representative of the protein, resulting in a series of frequencies and 439

amplitudes. The frequencies correspond to a physico-chemical property involved in the 440 biological activity of the protein. Comparison of proteins is performed by cross-spectra analysis. 441

Proteins with similar spectra were predicted to have a similar biological function. Inverse Fourier 442

Transform was performed to identify the sequence responsible for obtained signals at a given 443 frequency. 444

Transfection. HeLa cells (1 x 10 6 ) were seeded in a 60 mm culture dish 24 h prior to 445 transfection. AcGFP-TRP120 or AcGFP-control plasmids were added to OptiMem and 446 Lipofectamine 2000 mixture and incubated for 20 min at 37°C. Lipofectamine/plasmid mixtures 447 were added to HeLa cells and incubated for 4 h at 37°C. Media was aspirated 4 h post-448 transfection and fresh media was added to each plate and incubated for 24 h. then resuspended in RPMI media. To determine TRP120 or TRX protein coating of 475

FluoSpheres, dot blotting of FluoSpheres samples was performed after protein coating using α-476 TRX or α-TRP120 antibodies. 8 x 10 5 THP-1 cells/well were plated in a 96-well round bottom 477 plate, and the TRP120 or TRX coated FluoSpheres were added to each well at approximately 5 478 beads/cell. The cell and protein-coated FluoSpheres were incubated between 5-60 mins at 37°C 479 with 5% CO 2 , collected and unbound beads were washed twice with 1 X PBS, followed by 480 fixation by cytospin for 15 mins. Cell samples were then processed for analysis by 481 immunofluorescent confocal microscopy, as previously mentioned. FluoSpheres are light-482 sensitive, therefore all steps were performed in the dark. for 30 min at 4°C. Lysates were then cleared by centrifugation and protein abundance assessed 492 by bicinchoninic acid assay (BCA assay). Samples were added to Laemelli buffer then boiled for 493 5 min. Lysates were then subjected to SDS-PAGE followed by transfer to nitrocellulose 494 membrane. Membranes were blocked for 1 h in 5% nonfat milk diluted in TBST and then 495 exposed to α-TRP120, α-TRX or α-Notch-1 primary antibodies overnight. Membranes were 496 washed three times in Tris-buffered saline containing 1% Triton (TBST) for 30 min followed by 1 497 h incubation with horseradish peroxidase-conjugated anti-rabbit and anti-mouse secondary 498 antibodies (SeraCare, Milford, MA) (diluted 1:10,000 in 5% nonfat milk in TBST Subsequently, purified polyhistidine-tagged, full-length, truncated rTRP120 proteins, or rTRX 507 was pre-treated with 5-10 µg/ml of polyclonal rabbit anti-TRP120 antibody generated against the 520 TRP120 Notch mimetic SLiM (aa. 284-301), or purified IgG antibody. The cell-free E. 521 chaffeensis/antibody mixture was then added to THP-1 cells (5 x 10 5 ) in a 12-well plate for 2 h. 522

Samples were collected, washed with PBS and prepared for IFA. 523 TRP120 Protein Expression and Purification. Full length or truncated constructs of rTRP120, 524 or rTRX control were expressed in a pBAD expression vector, which has been previously 525 optimized by our laboratory (59, 61, 62) . Recombinant TRP120 full length, truncated constructs, 526 and rTRX were purified via nickel-nitrilotriacetic acid (Ni-NTA) purification system. All 527 recombinant proteins were dialyzed via PBS and tested for bacterial endotoxins using the 528 Limulus Amebocyte Lysate (LAL) test. 529 Statistical Analysis. All data are represented as the means ± standard deviation (SD) of data 530 obtained from at least three independent experiments done with triplicate biological replicates, 531 unless otherwise indicated. Analyses were performed using a two-way ANOVA or two-tailed 532

Student's t-test (GraphPad Prism 6 software, La Jolla, CA). A P-value of <0.05 was considered 533 statistically significant. 534

We thank the UTMB Solution Biophysics Laboratory and the Optical Microscopy Core for 536 assistance with confocal microscopy. This work was supported by the National Institute of 537 

Notch signaling pathway and gene expression profiles during early in 583 vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts

Notch signaling is a potent inducer of growth arrest and 587 apoptosis in a wide range of B-cell malignancies

Notch signaling: cell fate control and 589 signal integration in development

Notch1-591 mediated signaling induces MHC class II expression through activation of class II 592 transactivator promoter III in mast cells

Notch signaling in the immune system

The NOTCH1-autophagy interaction: Regulating self-eating for 595 survival

Notch signaling regulates expression of Mcl-1 and apoptosis in 598 PPD-treated macrophages

Arbiter of differentiation and death: Notch signaling meets 600 apoptosis

Notch receptor-ligand binding 602 and activation: insights from molecular studies

The many facets of Notch ligands

Interactome-wide prediction of 606 short, disordered protein interaction motifs in humans

ELM-the eukaryotic linear motif resource in 2020

Short linear motifs: ubiquitous and functionally diverse protein interaction modules 613 directing cell regulation

Attributes of short linear motifs

Ehrlichia chaffeensis exploits host SUMOylation 617 pathways to mediate effector-host interactions and promote intracellular survival

How viruses hijack cell regulation

How pathogens use linear motifs to perturb 622 host cell networks

Notch Signaling 624 Pathway Is Activated by Sulfate Reducing Bacteria

Pathogens use structural mimicry of native host ligands as a 628 mechanism for host receptor engagement

Molecular Mimicry: a Paradigm of Host-630

Microbe Coevolution Illustrated by Legionella. mBio 11

Molecular mimicry by an F-box effector of Legionella pneumophila hijacks a 633 conserved polyubiquitination machinery within macrophages and protozoa

Convergent evolution and mimicry of 636 protein linear motifs in host-pathogen interactions

Ehrlichia moonlighting effectors and 638 interkingdom interactions with the mononuclear phagocyte

Notch-1 Signaling Modulates Macrophage Polarization and 640 Immune Defense against Mycobacterium avium paratuberculosis Infection in 641 Inflammatory Diseases. Microorganisms 8

Use of the informational 643 spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: 644 prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target

Notch-Jagged complex structure implicates a catch bond in tuning 648 ligand sensitivity

Molecular basis for Jagged-1/Serrate ligand recognition by the 652 Notch receptor

Yeast two-hybrid, a 654 powerful tool for systems biology

Intrinsic 656 selectivity of Notch 1 for Delta-like 4 over Delta-like 1

Notch 658 ligand delta-like1: X-ray crystal structure and binding affinity

A conserved 661 face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-662 inhibition

Notch signaling and Notch signaling modifiers

Thrombospondin 2 potentiates 666 notch3/jagged1 signaling

F3/contactin 670 acts as a functional ligand for Notch during oligodendrocyte maturation

Anaplasma phagocytophilum AnkA is tyrosine-672 phosphorylated at EPIYA motifs and recruits SHP-1 during early infection

Molecular 675 characterization of the Dot/Icm-translocated AnkH and AnkJ eukaryotic-like effectors of 676 Legionella pneumophila

Comparative and functional 681 genomics of legionella identified eukaryotic like proteins as key players in host-pathogen 682 interactions

Distribution of 684 proline-rich (PxxP) motifs in distinct proteomes: functional and therapeutic implications 685 for malaria and tuberculosis

An intrinsic dominant negative activity of serrate 687 that is modulated during wing development in Drosophila

Dose-dependent mechanism of Notch action in promoting osteogenic 690 differentiation of mesenchymal stem cells

Activation of the Notch Signaling Pathway In Vivo 694 Elicits Changes in CSL Nuclear Dynamics

The Drosophila melanogaster Suppressor of deltex gene, a regulator 697 of the Notch receptor signaling pathway, is an E3 class ubiquitin ligase

Structural and functional properties of the human notch-1 ligand 701 binding region

Protein X-ray Crystallography and Drug Discovery. 703 Molecules 25

Major species-specific antibody epitopes of the 705

Ehrlichia chaffeensis p120 and E. canis p140 orthologs in surface-exposed tandem 706 repeat regions

SFAPS: an R package for structure/function analysis of 708 protein sequences based on informational spectrum method

Differentially expressed and 710 secreted major immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis 711 elicit early antibody responses to epitopes on glycosylated tandem repeats

A variable-length PCR target 714 protein of Ehrlichia chaffeensis contains major species-specific antibody epitopes in 715 acidic serine-rich tandem repeats

canonical/noncanonical Notch ligands demonstrating amino acid homology. An asterisk (*)

Informational Spectrum Method (ISM) was used to predict if TRP120 shared 722 similar biological function with canonical and nonocanonical Notch ligands. Primary sequences 723 of TRP120 and Notch ligands were converted into a numerical sequence-based electron ion 724 interaction potential (EIIP) of each amino acid. Numerical sequences were converted into a 725 spectrum using Fourier transform. To determine if proteins shared a similar biological function 726 and cross spectra analysis was performed and similar biological function is denoted by a peak 727 at a frequency of F(0.288). (C) Schematic of TRP120 N-C-(gray) and TR domains (blue)

ISM sequence shown in panel B (underlined). (*) represents a partial tandem repeat containing 730 similar (EDDTVSQPSLE) but non identical sequence to highlighted sequence

chaffeensis TRP120-TR interactions with the Notch receptor ligand binding 733 region (LBR). (A) HeLa cells transfected with TRP120-GFP (green) and probed for 734 endogenous Notch-1 (red) demonstrate colocalization by immunofluorescent microscopy

Colocalization was quantitated by Pearson's and Mander's coefficient (-1 no colocalization; +1 736 strong colocalization). (B and C) His-tag pull down assays demonstrating direct interaction 737 between TRP120 and Notch-1. Recombinant Fc-tagged Notch-1 LBR was incubated with

C) TRP120-TR-His or TRX-His negative control on Talon metal affinity resin

Bound Notch-1, TRP120-His, α-TRP120 against a TR peptide or TRX-His were detected with α-740

Notch-1, α-TRP120 or α-TRX antibodies. (D-F) Surface plasmon resonance of (D)

E) TRP120-TR-His or (F) TRX-His with Fc-tagged Notch-1 LBR on a Biacore T100 with a

NTA) sensor chip. TRP120-FL-His, TRP120-TR-His or TRX-His 743 were immobilized on the NTA chip and 2-fold dilutions

Sensograms and K D are 745 representative of data from triplicate experiments. (G) THP-1 cells were treated with rTRX

Colocalization 747 was visualized by confocal immunofluorescent microscopy. Notch-1 was immunostained with 748 tetramethylrhodamine isothiocyanate

White boxes 750 indicate areas of colocalization measurements. Scale bar = 10 μm. (H) Dot blot of PBS

TRP120-FL-coated microspheres probed with α-TRX or α-TRP120 antibodies, respectively

TRP120-TR activates Notch and NICD nuclear translocation in primary human 754 monocytes. (A) Soluble recombinant TRP120-TR or -C terminal proteins (2 µg/ml) were

incubated with THP-1 cells for 2 h. Cells were collected and NICD localization determined by 756

THP-1 cells were used as negative controls. E. chaffeensis-infected or recombinant

THP-1 cells were used as positive controls. NICD nuclear translocation was

B) Primary human monocytes were 760 treated with soluble TRP120-TR or recombinant TRX as described above and NICD nuclear 761 translocation was detected in E. chaffeensis-infected and TRP120-TR-treated cells. End point 762 analysis was performed as described in Fig. 2. Experiments were performed in triplicate and 763 representative images are shown

A TRP120-TR Notch-1 memetic IDD peptide stimulates NICD nuclear translocation

A) Overlapping TRP120-TR IDD peptide sequences (P1-P3) (B) THP-1 cells or (C) Primary 767 human monocytes were incubated with synthetic TRP120-TR IDD peptides to determine the 768

Notch-1 memetic motif responsible for Notch activation. TRP120-TR peptides were 769 overlapping peptides spanning an entire TR domain. Cells were treated with peptide (1 µg/ml

for 2 h and confocal immunofluorescent microscopy was used to visualize NICD localization

Ctrl-p) was used as 772 negative control and E.ch. infected cells were used as positive control. To determine if direct 773 interaction of the TRP120-N1-P3 peptide and Notch receptor was necessary for Notch 774 activation, THP-1 cells were pre-treated with DAPT, a γ-secretase inhibitor

Table of Notch 778 pathway genes with corresponding fold-change displaying differential expression (up, down or 779 no change) at 24 h p.t with 10 ng/ml of TRP120-N1-P3 peptide (B) Scatter plots of expression 780 array analysis of 84 Notch signaling pathway genes to determine Notch gene expression 24 h 781 after stimulation with 1 ng/ml (top

Purple lines denote a 2-fold up or down regulation in comparison to control, and the 783 black line denotes no change

A TRP120-TR Notch-1 memetic SLiM peptide activates Notch signaling

P4-P6) and mutant (dmut) peptide sequences. (B) THP-1 cells or (C) primary 788 human monocytes were treated with synthetic TRP120-TR SLiM peptides to identify the 789

TRP120-TR peptides were SLiM peptides spanning 790 the entire TRP120-N1-P3 peptide sequence. TRP120-N1-P3 mutant peptide (dmut) has a 791 deletion of the TRP120-N1-P6 amino acids. Cells were treated with peptide (1 µg/ml) for 2 h and 792 NICD localization visualized by confocal microscopy. TRP120-N1-P3 peptide was used as a 793 positive control. To determine if direct interaction of the TRP120-N1-P6 peptide and Notch 794 receptor was necessary for Notch activation

secretase inhibitor, and treated with TRP120-N1-P6 peptide for 2 h. Representative data of all 796 experiments are shown

TRP120-N1-P6 SLiM Notch memetic peptide stimulates Notch gene expression

Selected Notch pathway genes with corresponding fold-change displaying differential 800 expression (up-and downregulation) at 24 h p.t with 10 ng/ml of TRP120-N1-P6 peptide

Scatter plots of expression array analysis of 84 Notch signaling pathway genes to determine 802

Notch gene expression with 1 ng/ml, 10 ng/ml, 100 ng/ml of TRP120-N1-P6 peptide or

ng/ml) compared to untreated cells (bottom) at 24 p.t. Purple lines denote 804 a 2-fold up or down regulation in comparison to control

Scatter plots are representative of three independent experiments

Amino acids critical to TRP120-N1-P6 memetic SLiM activity and anti-SLiM 808 antibody blocks Notch activation (A) Critical amino acids of the TRP120-N1-P6 memetic 809

SLiM determined by alanine mutagenesis (mutant peptide sequences are shown above the 810 corresponding panel). THP-1 cells were treated with mutant peptides (dmut2

for 2 h and confocal immunofluorescent microscopy was used to visualize NICD localization

NICD nuclear translocation denotes Notch activation. Peptide dmut was used as a negative 813 control and TRP120-N1-P6 was used as a positive control. (B) Cell-free E. chaffeensis

µg/ml) for 30 min. Preimmune serum was used as control antibody. THP-1 cells were 816 subsequently inoculated with the cell-free E. chaffeensis/α-TRP120-N1-P6

confocal immunofluorescent microscopy was used to visualize NICD nuclear localization

Representative data of all experiments are shown

Purple lines denote a 2-fold up or down regulation in 847 comparison to control, and the black lines denotes no change